Pelthos Therapeutics's market cap is currently $81.67M. The company's EPS TTM is $; its P/E ratio is ―; Pelthos Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
